Christine Erikstrup Hallgreen

Christine Erikstrup Hallgreen

Associate Professor

Member of:


    1. 2014
    2. Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

      Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., Stoeckert, I. & 4 others, Waddingham, E., Tzoulaki, I., Ashby, D. & Wise, L., Sep 2014, In: Pharmacoepidemiology and Drug Safety. 23, 9, p. 974-983 10 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

      Mt-Isa, S., Hallgreen, Christine Erikstrup, Wang, N., Callréus, T., Genov, G., Hirsch, I., Hobbiger, S. F., Hockley, K. S., Luciani, D., Phillips, L. D., Quartey, G., Sarac, S. B., Stoeckert, I., Tzoulaki, I., Micaleff, A., Ashby, D. & IMI-PROTECT benefit-risk participants, I. B. P., Jul 2014, In: Pharmacoepidemiology and Drug Safety. 23, 7, p. 667-78 12 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    ID: 122745397